Kura Oncology, Inc.
KURA
$9.22
-$0.52-5.34%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 5.36% | -16.45% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 5.36% | -16.45% | |||
| Cost of Revenue | 1.64% | -5.07% | |||
| Gross Profit | -0.28% | 0.06% | |||
| SG&A Expenses | -19.38% | 19.18% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -6.30% | 2.84% | |||
| Operating Income | 8.64% | -7.84% | |||
| Income Before Tax | 9.39% | -9.19% | |||
| Income Tax Expenses | -88.73% | -- | |||
| Earnings from Continuing Operations | 9.46% | -9.29% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 9.46% | -9.29% | |||
| EBIT | 8.64% | -7.84% | |||
| EBITDA | 8.62% | -7.56% | |||
| EPS Basic | 10.03% | -8.79% | |||
| Normalized Basic EPS | 18.51% | -20.09% | |||
| EPS Diluted | 10.03% | -8.79% | |||
| Normalized Diluted EPS | 18.51% | -20.09% | |||
| Average Basic Shares Outstanding | 0.64% | 0.46% | |||
| Average Diluted Shares Outstanding | 0.64% | 0.46% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||